A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy ...

Tirzepatide works the same way. It is the active ingredient in both Mounjaro and Zepbound, both made by Eli Lilly. Mounjaro ...

The FDA issued a nationwide Class II recall of levothyroxine, a common thyroid medication, due to concerns over potency.

As Teva proceeds down the more muted growth path that it telegraphed early this year, the generics and innovative medicines ...

The FDA approved Simtriyo (centanafadine), making it the first and only approved norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit hyperactivity ...

Here are several medications Lindsay Clancy was prescribed in the months leading up to her children's deaths, according to two lawsuits.

Key Points Interested in Maplight Therapeutics, Inc.? Here are five stocks we like better. ML-007C-MA met the Phase II ...

While MapLight Therapeutics’ oral schizophrenia candidate reached the main endpoint of a Phase 2 trial, analysts say Bristol Myers Squibb’s Cobenfy is likely to hold its market share. MapLight ...

President Trump said TrumpRx is the biggest thing to happen in healthcare in decades. But an NPR analysis finds drugmakers ...

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the American Enterprise Institute found that insurance denials of first attempts to fill prescriptions for ...

The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a fundamentally new mechanism of action in more than half a century. Built on ...